Kathi Niffenegger
2023
In 2023, Kathi Niffenegger earned a total compensation of $453.4K as Former Chief Financial Officer at Edesa Biotech, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $102,080 |
|---|---|
| Option Awards | $49,488 |
| Salary | $253,391 |
| Other | $48,414 |
| Total | $453,373 |
Niffenegger received $253.4K in salary, accounting for 56% of the total pay in 2023.
Niffenegger also received $102.1K in bonus, $49.5K in option awards and $48.4K in other compensation.
Rankings
In 2023, Kathi Niffenegger's compensation ranked 2,091st out of 2,854 executives tracked by ExecPay. In other words, Niffenegger earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,091 out of 2,854 | 27th |
Division Manufacturing | 1,188 out of 1,574 | 25th |
Major group Chemicals And Allied Products | 721 out of 886 | 19th |
Industry group Drugs | 703 out of 849 | 17th |
Industry Pharmaceutical Preparations | 504 out of 614 | 18th |
Source: SEC filing on April 5, 2024.
Niffenegger's colleagues
We found three more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2023.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020